WASHINGTON - The U.S. military said on Friday it discovered even more suspected shipments of live anthrax than previously thought, both in the United States and abroad, and ordered a sweeping review of practices meant to inactivate the bacteria.
CHICAGO - A Phase III trial of Pfizer Inc's drug Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer.
- The University of Kansas Hospital said on Friday it was monitoring a patient for a possible Ebola infection after he returned from the West African nation of Sierra Leone and developed a fever.
PORTLAND, Ore. - The father of a University of Oregon student has contracted the potentially deadly meningococcal disease amid an outbreak that started in January and has killed one student, bringing the total number of people infected to seven, state health officials said on Friday.
(Reuters Health) - Obesity increases the risk for atrial fibrillation, a common heart rhythm disorder that can lead to blood clots, stroke and heart failure, a new analysis suggests.
NEW YORK - Bristol-Myers Squibb has sued a top cancer immunotherapy executive for violating confidentiality and non-compete agreements after he left for direct competitor AstraZeneca, court documents show.
(Reuters Health) - People’s estimates of how much they drink are much higher when they include weekends and holidays, according to a new survey from the UK.
SAN FRANCISCO - An Idaho law that prohibits abortions of fetuses 20 or more weeks after fertilization is unconstitutional, a U.S. appeals court ruled on Friday.
(Reuters Health) - Older women with early-stage breast cancer might be able to skip a lymph node biopsy without changing their survival odds, a small study suggests.
- A Merck & Co drug that helps the immune system fight cancer was about twice as effective as the current standard therapy for patients with recurrent or advanced head and neck cancers, according to study data released on Friday.